$DZSI
DZS INC.

2013 Q3 Form 10-Q Financial Statement

#000110168013000005 Filed on November 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2012 Q3
Revenue $31.52M $29.20M
YoY Change 7.94% -3.33%
Cost Of Revenue $19.61M $20.97M
YoY Change -6.48% 5.2%
Gross Profit $11.91M $8.232M
YoY Change 44.64% -19.88%
Gross Profit Margin 37.78% 28.19%
Selling, General & Admin $6.346M $7.281M
YoY Change -12.84% -5.58%
% of Gross Profit 53.3% 88.45%
Research & Development $3.934M $5.090M
YoY Change -22.71% -3.85%
% of Gross Profit 33.04% 61.83%
Depreciation & Amortization $100.0K $70.00K
YoY Change 42.86% -84.09%
% of Gross Profit 0.84% 0.85%
Operating Expenses $10.28M $12.37M
YoY Change -16.9% -4.88%
Operating Profit $1.627M -$4.139M
YoY Change -139.31% 51.56%
Interest Expense $25.00K $26.00K
YoY Change -3.85% -21.21%
% of Operating Profit 1.54%
Other Income/Expense, Net $0.00 -$19.00K
YoY Change -100.0% -165.52%
Pretax Income $1.602M -$4.184M
YoY Change -138.29% 52.98%
Income Tax $6.000K $14.00K
% Of Pretax Income 0.37%
Net Earnings $1.596M -$4.198M
YoY Change -138.02% 52.77%
Net Earnings / Revenue 5.06% -14.38%
Basic Earnings Per Share $0.05 -$0.14
Diluted Earnings Per Share $0.05 -$0.14
COMMON SHARES
Basic Shares Outstanding 31.48M shares 31.09M shares
Diluted Shares Outstanding 33.34M shares 31.09M shares

Balance Sheet

Concept 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.30M $10.30M
YoY Change 38.83% -42.13%
Cash & Equivalents $14.30M $10.27M
Short-Term Investments
Other Short-Term Assets $2.400M $2.600M
YoY Change -7.69% 0.0%
Inventory $21.18M $25.38M
Prepaid Expenses
Receivables $29.36M $26.11M
Other Receivables $0.00 $0.00
Total Short-Term Assets $67.25M $64.38M
YoY Change 4.46% -16.07%
LONG-TERM ASSETS
Property, Plant & Equipment $642.0K $637.0K
YoY Change 0.78% -87.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $251.0K $214.0K
YoY Change 17.29% 7.0%
Total Long-Term Assets $893.0K $851.0K
YoY Change 4.94% -84.24%
TOTAL ASSETS
Total Short-Term Assets $67.25M $64.38M
Total Long-Term Assets $893.0K $851.0K
Total Assets $68.14M $65.23M
YoY Change 4.46% -20.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.55M $11.66M
YoY Change -1.01% -3.61%
Accrued Expenses $8.700M $8.400M
YoY Change 3.57% -28.21%
Deferred Revenue
YoY Change
Short-Term Debt $10.00M $10.00M
YoY Change 0.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $30.20M $30.03M
YoY Change 0.56% -11.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.688M $4.018M
YoY Change -33.1% -8.68%
Total Long-Term Liabilities $2.688M $4.018M
YoY Change -33.1% -8.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.20M $30.03M
Total Long-Term Liabilities $2.688M $4.018M
Total Liabilities $32.88M $34.04M
YoY Change -3.41% -10.88%
SHAREHOLDERS EQUITY
Retained Earnings -$1.038B -$1.042B
YoY Change -0.34%
Common Stock $1.073B $1.073B
YoY Change 0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $35.26M $31.19M
YoY Change
Total Liabilities & Shareholders Equity $68.14M $65.23M
YoY Change 4.46% -20.55%

Cashflow Statement

Concept 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $1.596M -$4.198M
YoY Change -138.02% 52.77%
Depreciation, Depletion And Amortization $100.0K $70.00K
YoY Change 42.86% -84.09%
Cash From Operating Activities $1.540M -$2.730M
YoY Change -156.41% 143.75%
INVESTING ACTIVITIES
Capital Expenditures -$120.0K -$140.0K
YoY Change -14.29% -68.89%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$120.0K -$130.0K
YoY Change -7.69% -71.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 180.0K 20.00K
YoY Change 800.0% -75.0%
NET CHANGE
Cash From Operating Activities 1.540M -2.730M
Cash From Investing Activities -120.0K -130.0K
Cash From Financing Activities 180.0K 20.00K
Net Change In Cash 1.600M -2.840M
YoY Change -156.34% 90.6%
FREE CASH FLOW
Cash From Operating Activities $1.540M -$2.730M
Capital Expenditures -$120.0K -$140.0K
Free Cash Flow $1.660M -$2.590M
YoY Change -164.09% 286.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7229000 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11545000 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29356000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25820000 USD
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14935000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14668000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
216000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
103000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1072839000 USD
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1073387000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5699000 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5699000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
548000 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
548000 shares
CY2013Q3 us-gaap Assets
Assets
68140000 USD
CY2012Q4 us-gaap Assets
Assets
61724000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
60933000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
67247000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11119000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14301000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18190000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10274000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3182000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7916000 USD
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31116000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31553000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31553000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31116000 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
31000 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
31000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9738000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2769000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1566000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4206000 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
19608000 USD
us-gaap Cost Of Revenue
CostOfRevenue
55919000 USD
CY2012Q3 us-gaap Cost Of Revenue
CostOfRevenue
20966000 USD
us-gaap Cost Of Revenue
CostOfRevenue
61211000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-24000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-113000 USD
CY2013Q3 us-gaap Debt Instrument Basis Spread On Variable Rate
DebtInstrumentBasisSpreadOnVariableRate
0.030
us-gaap Depreciation And Amortization
DepreciationAndAmortization
234000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
266000 USD
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.09
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.05
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2013Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
248000 USD
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
248000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2305000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4916000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1702000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6118000 USD
us-gaap Gross Profit
GrossProfit
34023000 USD
us-gaap Gross Profit
GrossProfit
25884000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
8232000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
11907000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
61000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4184000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9651000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2960000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1602000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-134000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4316000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3841000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4739000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1217000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2027000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-225000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2014000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
43000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-179000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-53000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-58000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1864000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1326000 shares
us-gaap Interest Expense
InterestExpense
74000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
25000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
26000 USD
us-gaap Interest Expense
InterestExpense
53000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6127000 USD
CY2013Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6460000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
21404000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
21179000 USD
CY2013Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12693000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13226000 USD
CY2013Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2026000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2051000 USD
CY2013Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2067000 USD
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2067000 USD
CY2013Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
10200000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
29784000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
32883000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
61724000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68140000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
30195000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26065000 USD
CY2013Q3 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
10000000 USD
CY2013Q3 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0325
CY2013Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
25000000.0 USD
CY2013Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
0 USD
us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0025
CY2012Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
10000000 USD
CY2013Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
10000000 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9178000 USD
CY2013Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9485000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
181000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4870000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-325000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-271000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3439000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2751000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
1596000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-4198000 USD
us-gaap Net Income Loss
NetIncomeLoss
2882000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9714000 USD
us-gaap Operating Expenses
OperatingExpenses
30969000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
10280000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
12371000 USD
us-gaap Operating Expenses
OperatingExpenses
35469000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4139000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1627000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9585000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3054000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3752000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
39000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
407000 USD
CY2012Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-8000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1601000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
432000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3719000 USD
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2688000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
208000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
251000 USD
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-30000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-113000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1273000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-24000 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
325000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
329000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2590000 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2411000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
181000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
130000 USD
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1546000 USD
CY2012Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1573000 USD
CY2013Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1246000 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1499000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
857000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
719000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
466000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
884000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15251000 USD
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15577000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
583000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
642000 USD
CY2013Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
3777000 USD
CY2012Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
3758000 USD
CY2013Q1 us-gaap Quantifying Misstatement In Current Year Financial Statements Amount
QuantifyingMisstatementInCurrentYearFinancialStatementsAmount
600000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
5000000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5090000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11514000 USD
zhne Provision For Doubtful Accounts Receivable And Sales Returns
ProvisionForDoubtfulAccountsReceivableAndSalesReturns
1651000 USD
zhne Standard Product Warranty Time Period
StandardProductWarrantyTimePeriod
P1Y
zhne Termination Notice Period
TerminationNoticePeriod
P30D
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3934000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14835000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1041146000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1038264000 USD
us-gaap Revenue Recognition Multiple Element Arrangements
RevenueRecognitionMultipleElementArrangements
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-top:6px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue when the earnings process is complete. The Company recognizes product revenue upon shipment of product under contractual terms which transfer title to customers upon shipment, under normal credit terms, net of estimated sales returns and allowances at the time of shipment. Revenue is deferred if there are significant post-delivery obligations or if the fees are not fixed or determinable. When significant post-delivery obligations exist, revenue is deferred until such obligations are fulfilled. The Company&#8217;s arrangements generally do not have any significant post-delivery obligations. If the Company&#8217;s arrangements include customer acceptance provisions, revenue is recognized upon obtaining the signed acceptance certificate from the customer, unless the Company can objectively demonstrate that the delivered products or services meet all the acceptance criteria specified in the arrangement prior to obtaining the signed acceptance.&#160;In those instances where revenue is recognized prior to obtaining the signed acceptance certificate, the Company uses successful completion of customer testing as the basis to objectively demonstrate that the delivered products or services meet all the acceptance criteria specified in the arrangement. The Company also considers historical acceptance experience with the customer, as well as the payment terms specified in the arrangement, when revenue is recognized prior to obtaining the signed acceptance certificate. When collectability is not reasonably assured, revenue is recognized when cash is collected.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company makes certain sales to product distributors. These customers are given certain privileges to return a portion of inventory. Return privileges generally allow distributors to return inventory based on a percent of purchases made within a specific period of time. The Company recognizes revenue on sales to distributors that have contractual return rights when the products have been sold by the distributors, unless there is sufficient customer specific sales and sales returns history to support revenue recognition upon shipment. In those instances when revenue is recognized upon shipment to distributors, the Company uses historical rates of return from the distributors to provide for estimated product returns.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company derives revenue primarily from stand-alone sales of its products. In certain cases, the Company&#8217;s products are sold along with services, which include education, training, installation, and/or extended warranty services. As such, some of the Company&#8217;s sales have multiple deliverables. The Company&#8217;s products and services qualify as separate units of accounting and are deemed to be non-contingent deliverables as the Company&#8217;s arrangements typically do not have any significant performance, cancellation, termination and refund type provisions. Products are typically considered delivered upon shipment. Revenue from services is recognized ratably over the period during which the services are to be performed.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For multiple deliverable revenue arrangements, the Company allocates revenue to products and services using the relative selling price method to recognize revenue when the revenue recognition criteria for each deliverable are met. The selling price of a deliverable is based on a hierarchy and if the Company is unable to establish vendor-specific objective evidence of selling price (&#8220;VSOE&#8221;) it uses third-party evidence of selling price (&#8220;TPE&#8221;), and if no such data is available, it uses a best estimated selling price (&#8220;BSP&#8221;). In most instances, particularly as it relates to products, the Company is not able to establish VSOE for all deliverables in an arrangement with multiple elements. This may be due to infrequently selling each element separately, not pricing products within a narrow range, or only having a limited sales history. When VSOE cannot be established, the Company attempts to establish the selling price of each element based on TPE. Generally, the Company&#8217;s marketing strategy differs from that of the Company&#8217;s peers and the Company&#8217;s offerings contain a significant level of customization and differentiation such that the comparable pricing of products with similar functionality cannot be obtained. Furthermore, the Company is unable to reliably determine what similar competitor products&#8217; selling prices are on a stand-alone basis. Therefore, the Company is typically not able to determine TPE for the Company&#8217;s products.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When the Company is unable to establish selling price using VSOE or TPE, the Company uses BSP. The objective of BSP is to determine the price at which the Company would transact a sale if the product or service were sold on a stand-alone basis. The BSP of each deliverable is determined using average discounts from list price from historical sales transactions or cost plus margin approaches based on the factors, including but not limited to, the Company&#8217;s gross margin objectives and pricing practices plus customer and market specific considerations.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has established TPE for its training, education and installation services. TPE is determined based on competitor prices for similar deliverables when sold separately. These service arrangements are typically short term in nature and are largely completed shortly after delivery of the product. Training and education services are based on a daily rate per person and vary according to the type of class offered. Installation services are based on daily rate per person and vary according to the complexity of the products being installed.</font></div><div style="line-height:120%;padding-top:12px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Extended warranty services are priced based on the type of product and are sold in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> year durations. Extended warranty services include the right to warranty coverage beyond the standard warranty period. In substantially all of the arrangements with multiple deliverables pertaining to arrangements with these services, the Company has used and intends to continue using VSOE to determine the selling price for the services. The Company determines VSOE based on its normal pricing practices for these specific services when sold separately.</font></div></div>
us-gaap Sales Revenue Net
SalesRevenueNet
89942000 USD
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
29198000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
87095000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
31515000 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001101680
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31671986 shares
CY2012Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4976000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14516000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14539000 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4644000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
367000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1266000 USD
CY2013Q3 us-gaap Significant Purchase Commitment Remaining Minimum Amount Committed
SignificantPurchaseCommitmentRemainingMinimumAmountCommitted
11100000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
35257000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
31940000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</font></div></div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32599000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30927000 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31086000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33344000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31086000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31273000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31480000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30927000 shares
CY2013Q3 zhne Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
8650000 USD
CY2012Q4 zhne Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
8836000 USD
CY2013Q3 zhne Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
1675000 USD
CY2012Q4 zhne Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
2878000 USD
zhne Provision For Doubtful Accounts Receivable And Sales Returns
ProvisionForDoubtfulAccountsReceivableAndSalesReturns
1203000 USD
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
ZHONE TECHNOLOGIES INC
dei Trading Symbol
TradingSymbol
ZHNE

Files In Submission

Name View Source Status
0001101680-13-000005-index-headers.html Edgar Link pending
0001101680-13-000005-index.html Edgar Link pending
0001101680-13-000005.txt Edgar Link pending
0001101680-13-000005-xbrl.zip Edgar Link pending
exhibit101.htm Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zhne-20130930.xml Edgar Link completed
zhne-20130930.xsd Edgar Link pending
zhne-20130930_cal.xml Edgar Link unprocessable
zhne-20130930_def.xml Edgar Link unprocessable
zhne-20130930_lab.xml Edgar Link unprocessable
zhne-20130930_pre.xml Edgar Link unprocessable
zhne-9302013x10q.htm Edgar Link pending